# Hysan Pharmaceutical Co., Ltd. – FDA Inspection, Jun 12, 2025

Source: https://www.keypedia.com/records/fda_inspections/hysan-pharmaceutical-co-ltd/24fb6aa1-34d3-49fe-90bf-23c0c6ba1733
Source feed: FDA_Inspections

> FDA inspection 1274837 of Hysan Pharmaceutical Co., Ltd., June 12, 2025. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274837
- Company Name: Hysan Pharmaceutical Co., Ltd.
- Inspection Date: 2025-06-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 4

## Related Documents

- [FDA Inspection 1047429 - 2018-03-29](https://www.keypedia.com/records/fda_inspections/hysan-pharmaceutical-co-ltd/4c571815-cdb2-4a4c-8a8c-a289b1de074e)
- [FDA Inspection 941851 - 2015-09-10](https://www.keypedia.com/records/fda_inspections/hysan-pharmaceutical-co-ltd/b393d2c4-d54f-4753-80e6-1523d258448f)
- FDA Inspection 822258 - 2012-10-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/hysan-pharmaceutical-co-ltd/8b76f14f-78cf-44ad-8a25-6d2053566c1a

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
